These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27131142)

  • 21. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
    Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
    Front Immunol; 2020; 11():2130. PubMed ID: 33013898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV).
    Zumla A; Alagaili AN; Cotten M; Azhar EI
    BMC Med; 2016 Sep; 14(1):132. PubMed ID: 27604081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Emerging viral diseases in Europe].
    Löbermann M; Gürtler LG; Eichler-Löbermann B; Reisinger EC
    Dtsch Med Wochenschr; 2012 Apr; 137(17):900-5. PubMed ID: 22511281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New global viral threats.
    Erdem H; Ünal S
    Saudi Med J; 2015 Apr; 36(4):393-8. PubMed ID: 25828274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of viral diseases: mathematical modeling as a tool for infection control, policy and decision making.
    Louz D; Bergmans HE; Loos BP; Hoeben RC
    Crit Rev Microbiol; 2010 Aug; 36(3):195-211. PubMed ID: 20218764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular manifestations of emerging viral diseases.
    Venkatesh A; Patel R; Goyal S; Rajaratnam T; Sharma A; Hossain P
    Eye (Lond); 2021 Apr; 35(4):1117-1139. PubMed ID: 33514902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical management and infection control of SARS: lessons learned.
    Cheng VC; Chan JF; To KK; Yuen KY
    Antiviral Res; 2013 Nov; 100(2):407-19. PubMed ID: 23994190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review on Emerging Infectious Diseases Prioritized Under the 2018 WHO Research and Development Blueprint: Lessons from the Indian Context.
    Kojom LP; Singh V
    Vector Borne Zoonotic Dis; 2021 Mar; 21(3):149-159. PubMed ID: 33316200
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel respiratory viruses: what should the clinician be alert for?
    Payne B; Bellamy R
    Clin Med (Lond); 2014 Dec; 14 Suppl 6():s12-6. PubMed ID: 25468912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging respiratory infections threatening public health in the Asia-Pacific region: A position paper of the Asian Pacific Society of Respirology.
    Park S; Park JY; Song Y; How SH; Jung KS;
    Respirology; 2019 Jun; 24(6):590-597. PubMed ID: 30985968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism.
    Meliopoulos VA; Karlsson EA; Kercher L; Cline T; Freiden P; Duan S; Vogel P; Webby RJ; Guan Y; Peiris M; Thomas PG; Schultz-Cherry S
    J Virol; 2014 Nov; 88(22):12982-91. PubMed ID: 25210188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging and re-emerging viral infections in Europe.
    Pugliese A; Beltramo T; Torre D
    Cell Biochem Funct; 2007; 25(1):1-13. PubMed ID: 16944546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2.
    Al-Tawfiq JA; Garout MA; Gautret P
    Infez Med; 2020 Jun; 28(suppl 1):64-70. PubMed ID: 32532941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic analysis and geographic visualization of H5N1 and SARS-CoV.
    Hill AW; Alexandrov B; Guralnick RP; Janies D
    AMIA Annu Symp Proc; 2007 Oct; ():975. PubMed ID: 18694075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging respiratory tract viral infections.
    Hui DS; Zumla A
    Curr Opin Pulm Med; 2015 May; 21(3):284-92. PubMed ID: 25764021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EDs on heightened alert for MERS-CoV as first cases reach the US.
    ED Manag; 2014 Jul; 26(7):73-7. PubMed ID: 24968569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors that make an infectious disease outbreak controllable.
    Fraser C; Riley S; Anderson RM; Ferguson NM
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6146-51. PubMed ID: 15071187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Certainties and uncertainties facing emerging respiratory infectious diseases: lessons from SARS.
    Chen YC; Chang SC; Tsai KS; Lin FY
    J Formos Med Assoc; 2008 Jun; 107(6):432-42. PubMed ID: 18583213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.